CISA is updating the National Cyber Incident Response Plan with a focus on improving coordination and response strategies for cybersecurity incidents. The update aims to enhance collaboration between federal agencies and the private sector to effectively respond to cyber threats and protect critical infrastructure.
Neurocrine Lands FDA Nod for First New Treatment in Decades for Rare Endocrine Disorder
The FDA has approved Neurocrine Biosciences’ Crenessity, a new therapy for rare endocrine disorder Congenital Adrenal Hyperplasia (CAH). Designed to block the corticotropin-releasing factor type
